"We want to see non-public wellbeing insurers jumping in and realising that funding someone's treatment-resistant depression to get a lifetime is more expensive than a copyright assisted therapy which can put them in remission For many years, or extended, from just one therapy." Scientists turned serious about psilocybin And the way its effects wi